Interleukin 2 for patients with renal cancer.
Rosenberg
Steven A
SA
D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis / Q000473:pathology / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome
D007376:Interleukin-2